logo
Meet Reem AlZarouni, UAE's reading champion who's fighting climate change with bots

Meet Reem AlZarouni, UAE's reading champion who's fighting climate change with bots

Khaleej Times27-07-2025
From books to bots — the UAE champion of the Arab Reading Challenge, 14-year-old Reem AlZarouni, is now using bots to fight climate change.
The young Emirati from Al-Ittihad National Private School has invented 'PermaBot,' a device that could help detect dangerous permafrost thawing and alert communities before disaster strikes.
The bot is a smart automated system designed to monitor permafrost, which is the frozen layer of soil found in some of the coldest regions on Earth. This phenomenon causes the frozen layer to potentially, over time, release toxic methane gases into the environment, making it a ticking climate bomb.
Stay up to date with the latest news. Follow KT on WhatsApp Channels.
'The problem of permafrost is often overlooked, and I invented this bot to detect such contingencies and to protect organisms around it,' Reem told Khaleej Times.
Reem's understanding in the field of climate is evident as she ranked among the top 30 winners in UNICEF's Net Zero Hero competition across the UAE, for her efforts in projects related to permafrost, plastic use, and waste recycling.
'Winning Net Zero Hero was more than just an award. It was a turning point that taught me age doesn't matter in making a difference,' she said, adding, 'Sustainability Practices are important and I try to implement them in my daily life as well as to raise awareness within our communities.'
Passion in lit and tech
The eighth-grader's victory against tens of thousands of students in the Arab Reading Challenge shaped her approach to problem-solving. Where others see separate interests, Reem sees connections between her passions in literature and technology.
'This was truly one of the most memorable moments in my life,' she told Khaleej Times about her reading triumph. 'Our country always pushed us to dream big, and I felt a deep sense of pride to even represent it in the finals."
Reem juggles different practices at once and is always out for more. 'Balancing is not about doing everything at once; it's doing the right thing at the right time. My key is being organised and doing the work I am passionate about, so it counts as free time,' she explained.
Family support fuels her achievements. 'My biggest support system was my family. They believed in my capabilities from my first step, encouraged me to dream big, and cheered me in each competition,' she shared.
For young people wanting to pursue their interests and passions, Reem has a clear message: 'Believe in your voice, your ideas, and your power to make a difference. You don't have to wait to be an adult to make a difference, always dare yourself and take small steps at a time."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UAE: AI outperforms human radiologists, records zero false negatives
UAE: AI outperforms human radiologists, records zero false negatives

Khaleej Times

time9 hours ago

  • Khaleej Times

UAE: AI outperforms human radiologists, records zero false negatives

A comprehensive study on an AI model developed by Abu Dhabi-based healthcare group M42 has found that it can safely and accurately detect tuberculosis from chest X-rays — outperforming human radiologists. Published in the prestigious scientific journal npj Digital Medicine – Nature, the study conducted in collaboration with Abu Dhabi's Capital Health Screening Centre (CHSC) is among the largest real-world clinical validations of an AI-driven healthcare solution to date, analyzing over one million chest X-rays to evaluate the efficacy and scalability of AI in TB screening. The study assessed AI Radiology in Screening TB (AIRIS-TB), M42's cutting-edge AI model engineered to streamline routine tuberculosis screenings, allowing radiologists to focus on more complex or urgent cases. The model demonstrated exceptional performance, indicating high diagnostic accuracy and an unprecedented 0 percent of false negatives. This means that the model has the potential to safely automate up to 80 percent of routine chest X-ray assessments, directly reducing the workload of radiologists, minimising the risk of human error, and delivering significant cost efficiencies in high-throughput low-prevalence settings. Labour-intensive Currently, reviews of chest X-rays remains labor-intensive and prone to oversight and error, potentially leading to missed or delayed diagnoses. A prior study has indicated a 26.6 percent increase in missed findings when radiologists double their annotation speed, and a rise in errors after 9 hours into their shift. AIRIS-TB delivered consistently strong performance across a wide range of demographic groups, including variations in gender, age, HIV status, income levels, and a diverse population covering six World Health Organization (WHO) regions, highlighting the model's robustness, fairness and generalizability across diverse global populations. These results indicate the model's potential to significantly improve clinical workflows and drive earlier, more equitable screening of TB in high-volume programs worldwide. "This landmark study marks a pivotal moment in the potential power of AI in the global fight against tuberculosis,' said Dimitris Moulavasilis, Group CEO of M42. 'Our AIRIS-TB model stands as a compelling testament to the unmatched accuracy, safety and scalability that AI can deliver, particularly in resource-limited settings where there is a shortage of radiologists and the need to tackle TB is greatest.' He added that in regions with a high prevalence of TB, the model offers a 'scalable technological solution' that can help save lives. 'These results signal the transformative role AI can play in reshaping global public health and redefining how healthcare is diagnosed, delivered and experienced worldwide,' he said. The study underwent rigorous peer review and ethical oversight by the Department of Health – Abu Dhabi, ensuring transparency, accountability, and the highest standards of clinical integrity. Its publication in a leading scientific journal reinforces M42's position as a global pioneer in AI-led health solutions and solidifies the UAE's growing prominence as a global, data-driven hub for cutting-edge medical innovation and technology.

M42 announces breakthrough results for its AI-powered tuberculosis screening
M42 announces breakthrough results for its AI-powered tuberculosis screening

Zawya

time9 hours ago

  • Zawya

M42 announces breakthrough results for its AI-powered tuberculosis screening

M42, a global health leader powered by technology, artificial intelligence (AI) and genomics, has unveiled landmark findings from a large-scale population study on AI-powered tuberculosis (TB) screening, published in the prestigious scientific journal npj Digital Medicine - Nature. Conducted in collaboration with Capital Health Screening Centre (CHSC) in Abu Dhabi, part of the M42 group, the study is among the largest real-world clinical validations of an AI-driven healthcare solution to date, analyzing over one million chest X-rays (CXRs) to evaluate the efficacy and scalability of AI in TB screening. The study assessed AI Radiology in Screening TB (AIRIS-TB), M42's cutting-edge AI model engineered to streamline routine tuberculosis screenings, allowing radiologists to focus on more complex or urgent cases. AIRIS-TB demonstrated exceptional performance, achieving an Area Under the Receiver Operating Characteristic Curve (AUROC) of 98.5% - a clear indicator of its high efficiency in triaging CXRs for TB. With an estimated 10.8 million people falling ill from TB and a total of 1.25 million people dying from it in 2023, according to the World Health Organisation (WHO), and recent reports of TB returning to being the world's leading cause of death from a single infectious agent, M42's AIRIS-TB demonstrates the potential of AI solutions delivering real-world impact. AIRIS-TB reported an unprecedented 0% false-negative rate for tuberculosis-specific cases across the full dataset – an achievement that reinforces its safety and reliability as a workflow automation tool. In practical application, the model has the potential to safely automate up to 80% of routine CXR assessments, directly alleviating radiologist workload pressures, minimising the risk of human error, and delivering significant cost efficiencies in high-throughput low-prevalence settings. Presently, CXR review remains labor-intensive and prone to oversight and error, potentially leading to missed or delayed diagnoses, with a prior study stating a 26.6% increase in missed findings when radiologists double their annotation speed, and a rise in errors after 9 hours into their shift. Importantly, AIRIS-TB delivered consistently strong performance across a wide range of demographic groups, including variations in gender, age, HIV status, income levels, and a diverse population covering six WHO regions, highlighting the model's robustness, fairness and generalisability across diverse global populations. These results underscore AIRIS-TB's potential to significantly enhance clinical workflows and drive earlier, more equitable screening of TB in high-volume programmes worldwide. Dimitris Moulavasilis, Group CEO of M42, said, "This landmark study marks a pivotal moment in the potential power of AI in the global fight against tuberculosis. Our AIRIS-TB model stands as a compelling testament to the unmatched accuracy, safety and scalability that AI can deliver, particularly in resource-limited settings where there is a shortage of radiologists and the need to tackle TB is greatest. In regions with a high prevalence of TB, we now have a scalable technological solution that can bridge the divide, expand radiologist capacity and help save lives. These results signal the transformative role AI can play in reshaping global public health and redefining how healthcare is diagnosed, delivered and experienced worldwide.' Dr. Laila Abdel Wareth, CEO of Capital Health Screening Centre, added, "The outcomes of this study reaffirm that AI models like AIRIS-TB can not only match – but safely surpass – human-level accuracy and efficiency in clinical practice. By automating high-volume, routine screenings with precision, we are equipping radiologists to concentrate on complex and high-risk cases, unlocking greater diagnostic capacity. This shift holds immense potential to elevate patient outcomes, streamline healthcare delivery and bolster public health infrastructure on a global scale." The study underwent rigorous peer review and ethical oversight by the Department of Health – Abu Dhabi, ensuring transparency, accountability, and the highest standards of clinical integrity. Its publication in a leading scientific journal reinforces M42's position as a global pioneer in AI-led health solutions and solidifies the UAE's growing prominence as a global, data-driven hub for cutting-edge medical innovation and technology. The full study is accessible through npj Digital Medicine.

NYU Abu Dhabi study uncovers how life can survive on Mars
NYU Abu Dhabi study uncovers how life can survive on Mars

The National

time19 hours ago

  • The National

NYU Abu Dhabi study uncovers how life can survive on Mars

Life may be able to survive beneath the surface of Mars and other planets because of energy generated by cosmic rays, researchers from the New York University Abu Dhabi (NYUAD) have found. The new study, published in the International Journal of Astrobiology on July 28, suggests that future missions looking for microscopic life may need to dig deeper into the surface. Dr Dimitra Atri, principal investigator at NYUAD's Centre for Astrophysics and Space Science and lead author of the study, told The National that underground regions where cosmic radiation can trigger chemical reactions may be more promising, instead of surface environments warmed by sunlight. 'For decades, most of our ideas about where life might thrive beyond Earth have revolved around sunlight or heat from a planet's interior,' he said. 'But there are places in our solar system, like Mars, Europa (one of Jupiter's moons), and Enceladus (a moon of Saturn) where there just isn't enough sunlight or geothermal heat. It made me ask: could there be another way for life to get energy in these dark, cold places?' How the study worked The study explores how high-energy particles from space, known as cosmic rays, can penetrate below the surface of planetary bodies with thin or no atmospheres, such as Mars and the icy moons. When cosmic rays interact with underground water or ice, they can break apart water molecules in a process called radiolysis, producing energy-rich compounds like hydrogen. 'We have learnt from Earth that some microbes deep underground, cut off from sunlight, can survive using energy from the natural breakdown of radioactive minerals in rocks,' said Dr Atri. 'This process, called radiolysis, splits water molecules and produces chemicals like hydrogen gas, which some bacteria can use. It is not just theory, this is something we have observed in places like deep South African gold mines.' How does the study change our understanding? For decades, habitability was thought to be limited to planets within the "Goldilocks Zone", the region around a star where temperatures are just right for liquid water to exist on the surface. But this new study introduces a different concept: the Radiolytic Habitable Zone (RHZ), an underground region where cosmic rays could generate enough energy to support microbial life without being too damaging. It suggests that life may also thrive in cold, sunless environments deep beneath the surface. 'The big idea was … could cosmic ray-induced radiolysis carve out a 'habitable zone' beneath the surfaces of these worlds, providing a steady and reliable energy source for microbes?' said Dr Atri. The research focused on Mars, Europa and Enceladus, which are all known to have ice or possible liquid water under their surfaces. The computer simulations showed that Enceladus had the most potential to support life in this way, followed by Mars and then Europa. Dr Atri said this work should influence how scientists design future space missions and where they target their life-detection instruments. 'If we take radiolysis seriously, we need to design missions that can drill or sense a few metres below the surface, not just scratch the top layer,' he said. 'Instruments would need to look for chemical signatures of radiolysis, like certain gases or organic molecules linked to microbial life powered by this process. 'It also means focusing on places with thinner ice or rock where cosmic rays can penetrate and water might be present, say, fissures on Enceladus, cracks in Europa's ice, or subsurface layers on Mars.' He said that if mission planners ignore the effects of cosmic rays and radiolysis, they 'could miss the promising habitats in the solar system'. How will the findings shape future missions? Most Mars missions so far have focused on the surface, but newer ones are looking to dig deeper for signs of underground life. The European Space Agency's Rosalind Franklin rover, now set to launch in 2028 after multiple delays, will carry a drill that can dig two metres below the surface to search for signs of life. Nasa's Perseverance rover has been collecting soil and rock samples from the Jezero Crater on Mars since 2021, although it drills only shallow depths. The study is also interesting because cosmic rays are typically seen as harmful, especially for humans, but this research argues that high-energy particles could be a source of energy for life underground. 'Cosmic rays are definitely a double-edged sword. They damage DNA, disrupt cell function, and, at the surface, are a big problem for both life and future astronauts,' said Dr Atri. 'That's why Earth's magnetic field and atmosphere are so important, they shield us from most of this radiation. 'But when cosmic rays hit water or ice underground, they trigger radiolysis, breaking apart water molecules and producing energy-rich compounds that some microbes could use. So, while life on the exposed surface would be at risk, microbes just the right distance below, shielded from the worst of the radiation but still close enough to get radiolysis by-products, could actually benefit.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store